tradingkey.logo
tradingkey.logo
Suchen

Twist Bioscience Corp

TWST
Zur Watchlist hinzufügen
99.240USD
-3.010-2.94%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
6.17BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Twist Bioscience Corp Unternehmen

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Twist Bioscience Corp Informationen

BörsenkürzelTWST
Name des UnternehmensTwist Bioscience Corp
IPO-datumOct 31, 2018
CEOLeproust (Emily M)
Anzahl der mitarbeiter979
WertpapierartOrdinary Share
GeschäftsjahresendeOct 31
Addresse681 Gateway Blvd.
StadtSOUTH SAN FRANCISCO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94080
Telefon18007190671
Websitehttps://www.twistbioscience.com/
BörsenkürzelTWST
IPO-datumOct 31, 2018
CEOLeproust (Emily M)

Führungskräfte von Twist Bioscience Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
17.75K
-16.90%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
13.28K
--
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
7.12K
-84.57%
Ms. Trynka Shineman Blake
Ms. Trynka Shineman Blake
Director
Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Twist Bioscience Corp?

Die fünf größten Anteilseigner von Twist Bioscience Corp sind: Dr. Emily M. Leproust, Ph.D.

Wie viele Institutionen halten Anteile an Twist Bioscience Corp (TWST)?

Mit Stand vom 2026Q1 halten 592 Institutionen Anteile an Twist Bioscience Corp, mit einem Gesamtmarktwert von etwa 78.48M, was 126.03% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -339291.00 gestiegen.

Was ist die größte Einnahmequelle von Twist Bioscience Corp?

Am 2026Q1 erzielte das Geschäft mit NGS applications für Twist Bioscience Corp den höchsten Umsatz in Höhe von 52.64M, was 50.76% des Gesamtumsatzes entspricht.